机构：[1]Department of Medicine Sinai Medical Center, New York, New York[2]Department of Cardiovascular Medicine Jefferson Medical College, Wynnewood, Pennsylvania[3]Department of Cardiology Institute of Cardiology and Center of Excellence on Aging, ‘G.D’Annunzio’’ University, Chieti, Italy[4]TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital Boston,Massachusetts[5]Department of Clinical Development Daiichi Sankyo Pharma Development, Edison, New Jersey
第一作者机构：[1]Department of Medicine Sinai Medical Center, New York, New York
通讯作者：
通讯机构：[4]TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital Boston,Massachusetts[*1]TIMI Study Group 350 Longwood Avenue, First Floor Offices Boston, MA 02115
推荐引用方式(GB/T 7714)：
Anna Plitt,Michael D. Ezekowitz,Raffaele De Caterina,et al.Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48[J].CLINICAL CARDIOLOGY.2016,39(6):345-346.doi:10.1002/clc.22537.
APA：
Anna Plitt,Michael D. Ezekowitz,Raffaele De Caterina,Francesco Nordio,Nancy Peterson&Robert P. Giugliano.(2016).Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48.CLINICAL CARDIOLOGY,39,(6)
MLA：
Anna Plitt,et al."Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48".CLINICAL CARDIOLOGY 39..6(2016):345-346
